eLife Sciences Publications Limited
eLife is a unique collaboration between funders and practitioners of research to communicate influential discoveries in the life and biomedical sciences in the most effective way.
|Telephone:||+44 (0)1223 855340|
|Address:||24 Hills Road, Cambridge|
|Membership type:||Corporate 6-20 (£250+VAT pa)|
We are a joint initiativeof the Howard Hughes Medical Institute, the Max Planck Society, and the Wellcome Trust. Along with a growing number of public and private research funders worldwide, these three organisations recognise that the communication of research results is as fundamental a component of the research process as the experiments themselves. Disseminating new findings as widely and effectively as possible maximises the value of research investments. The first step in the initiative is to establish a new, top-tier open-access journal covering basic biological research through to applied, translational and clinical studies.
The eLife journal will be a platform for extending the reach and influence of new discoveries and to showcase new approaches to the presentation, use, and assessment of research.
eLife, the open-access journal for outstanding advances in life science and biomedicine, is delighted to congratulate its Editor-in-Chief Randy Schekman on being awarded the 2013 Nobel Prize in Physiology or Medicine. He shares the prize with James Rothman and Thomas Südhof for their “discoveries of machinery regulating vesicle traffic, a major transport system in our cells”.
9 October 2013Read in full
eLife, the open-access journal for outstanding advances in life science and biomedicine, reveals a fresh approach to presenting and using scientific content on its new website.
19 December 2012Read in full
Head of Product
Three of the world’s leading scientific research funders – the Wellcome Trust, the Max Planck Society and the Howard Hughes Medi...